ClinConnect ClinConnect Logo
Search / Trial NCT03268837

Programmed Intermittent Bolus During Continuous Interscalene Nerve Block for Shoulder Arthroplasty

Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Aug 29, 2017

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is testing a new way to manage pain after shoulder surgery called the "programmed intermittent bolus" (PIB) technique. Unlike traditional methods that slowly deliver pain medication over an hour, the PIB technique gives a larger dose in just a few minutes each hour. The researchers want to see if this method helps patients feel less pain and be more satisfied with their pain control after total shoulder arthroplasty, a surgery typically done for severe shoulder arthritis.

To participate in this study, you need to be an adult in good health (classified as ASA Physical Status I to III) and able to communicate in English. Unfortunately, individuals with certain conditions like a high body mass index (BMI over 40), severe respiratory issues, or chronic pain conditions may not be eligible. If you join the study, you'll receive either the PIB technique or the traditional pain management method, and your pain levels will be closely monitored to see which method works better. This trial is currently looking for volunteers, and your participation could help improve pain management for future shoulder surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients
  • American Society of Anesthesiologists (ASA) Physical Status I to III
  • Exclusion Criteria:
  • Body mass index (BMI) \> 40
  • Not able to communicate in ENglish
  • Unable to obtain consent
  • Infection over site of placement
  • Severe respiratory disease
  • Cognitive or psychiatric history that would make it difficult to assess pain score
  • Complex regional pain syndrome
  • Chronic pain condition such as fibromyalgia, neuropathic pain
  • Preoperative opioid use greater than the equivalent of morphine 50 mg PO daily
  • Allergy to any of the study drug
  • Coagulopathy

About London Health Sciences Centre Research Institute Or Lawson Research Institute Of St. Joseph's

The London Health Sciences Centre Research Institute, affiliated with Lawson Health Research Institute at St. Joseph's Health Care, is dedicated to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into practical applications, the institute fosters collaboration among leading researchers, clinicians, and healthcare professionals. It aims to improve patient outcomes and enhance the quality of care through rigorous investigation in areas such as cancer, cardiovascular health, and neuroscience. By integrating cutting-edge research with clinical practice, the institute plays a pivotal role in shaping the future of healthcare delivery in the community and beyond.

Locations

London, Ontario, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials